14:00 EDT Niagen CFO expects Parkinson’s trial results in early 2026
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NAGE:
- Niagen Bioscience CFO says ‘very conservative’ in how business run
- Niagen Bioscience Raises 2025 Sales Outlook Amid FDA Ruling
- Fifth Third buying Comerica, AMD gets OpenAI boost: Morning Buzz
- Niagen Bioscience raises FY25 revenue view to up 25%-30% from up 22%-27%
- Niagen Bioscience’s Niagen IV, injections now available at iCRYO clinics